|
Global Impurity Control: Genotoxicity, Nitrosamines, and Beyond 2026 Conference
|
|
1
|
326
|
August 31, 2026
|
|
FDA Announcement - Small Molecule Nitrosamines in Infusion Bags
|
|
21
|
3233
|
August 28, 2026
|
|
An unexpected nitrosamine product of oclacitinib: Synthesis, structural elucidation, ADMET profiling and preliminary toxicological assessment-Pub
|
|
4
|
296
|
August 26, 2026
|
|
Nitrosamine formation in HPMC capsules
|
|
4
|
266
|
August 25, 2026
|
|
Mitigating Nitrosamine Risk through Twin Screw Melt Granulation in Metformin Hydrochloride
|
|
1
|
175
|
August 25, 2026
|
|
Use of conversion factors
|
|
6
|
603
|
August 25, 2026
|
|
N-Nitroso N-desethyl sunitinib in Sunitinib capsules
|
|
1
|
131
|
August 24, 2026
|
|
Establishing a Robust High Performance Liquid Chromatography−Ultraviolet Detection Technique for Nitrite Quantification in Pharmaceutical Excipients and Active Pharmaceutical Ingredients-Pub
|
|
0
|
145
|
August 22, 2026
|
|
Formation of N-nitroso dabrafenib in the dabrafenib API?
|
|
4
|
264
|
August 22, 2026
|
|
Approaching the Solid-Phase Reaction Limit: Nitrosation of 4-Phenylpiperidine Hydrochloride in Dense Slurries-Pub
|
|
0
|
112
|
August 20, 2026
|
|
In Hyderabad Next Week
|
|
3
|
231
|
August 20, 2026
|
|
From Detection to Prediction: AI-driven Process Analytical Technology for Nitrosamine and NDSRI Control in Pharmaceuticals-Pub
|
|
0
|
174
|
August 19, 2026
|
|
A Rapid and Sensitive LC–MS/MS Method for Quantification of NDSRI in Melatonin Drug Product via Controlled In Situ Formation-Pub
|
|
0
|
141
|
August 14, 2026
|
|
The TGA updated information for acceptable intake of nitrosamine impurities in medicines on 14 August 2026
|
|
0
|
495
|
August 14, 2026
|
|
N-Nitroso Metamizole Impurity C
|
|
5
|
578
|
August 11, 2026
|
|
Fiscal Year 2026 Generic Drug Science and Research Initiatives Public Workshop
|
|
7
|
531
|
August 11, 2026
|
|
An Analytical Quality by Design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product-Pub
|
|
2
|
273
|
August 8, 2026
|
|
🛑 N-nitroso Ticagrelor
|
|
32
|
4476
|
August 8, 2026
|
|
N Nitroso Tadalfil
|
|
19
|
1524
|
August 7, 2026
|
|
Nitrosamine Control Strategy for Products within the Scope of ICH S9
|
|
5
|
368
|
August 7, 2026
|
|
Differential Mutagenic Response of Rat Liver and Lung to Nicotine-Derived Nitrosamine Ketone (NNK)-Pub
|
|
0
|
116
|
August 5, 2026
|
|
Determination of Trace Nitrosamines in Plastic Pharmaceutical Packaging Materials
|
|
2
|
210
|
August 4, 2026
|
|
Nitrosamine risk assessment for short-term therapies: lifetime assumptions versus less-than-lifetime (LTL) exposure
|
|
2
|
235
|
August 4, 2026
|
|
🦺 A new Home, the same community!
|
|
38
|
869
|
August 3, 2026
|
|
🇺🇸 FDA updates 'estimated duration' dates on Recommended Interim AI limits
|
|
1
|
272
|
August 3, 2026
|
|
🇺🇸 FDA Control of Nitrosamine Impurities in Human Drugs revision2
|
|
63
|
7190
|
October 3, 2025
|
|
N-Nitroso meglumine
|
|
34
|
3134
|
August 1, 2026
|
|
N-Nitroso Abacavir Impurity possibility in physical state as standard
|
|
5
|
177
|
August 1, 2026
|
|
QSAR Toolbox - Free software. Any experience?
|
|
22
|
2717
|
July 31, 2026
|
|
Integrating nitrosamine theoretical formation into Translational Pharmaceutics: Mitigating risks during accelerated formulation development in early phase clinical studies-Pub
|
|
0
|
145
|
July 28, 2026
|